State of the clinical research For both compounds, the published clinical research in humans is limited: BPC-157 has not received approval as a medicine in any major regulatory jurisdiction (UK MHRA, EU EMA, US FDA)
GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis
Improves skin texture and clarity over time
Al-Saleh I, Al-Doush I, Alsabbaheen A, Mohamed GED, Rabbah A
Pregnancy, nursing, and autoimmune conditions require provider caution
Blend Composition PEPTIDE COMPONENTS BPC-157: 5mg (Body Protection Compound) GHK-Cu: 35mg (Copper Peptide) TB-500: 10mg (Thymosin Beta-4 Fragment) Ratio: 1:7:2 (BPC:GHK:TB) PHYSICAL PROPERTIES Total Weight: 50mg peptide blend Form: Lyophilized powder blend Color: Light blue tint (from GHK-Cu) Storage: Keep refrigerated 3646 F (28 C) Related products Thymulin $45.00 $65.00Price range: $45.00 through $65.00